Abstract-It is not fully known whether maternal prehypertension is associated with increased risk of adverse fetal outcomes, and it is debated whether increases in blood pressure during pregnancy influence adverse fetal outcomes. We performed a population-based cohort study in nonhypertensive women with term (≥37 weeks) singleton births (n=157 446). Using normotensive (diastolic blood pressure [DBP] <80 mm Hg) women as reference, we calculated adjusted odds ratios with 95% confidence intervals between prehypertension (DBP 80-89 mm Hg) at 36 gestational weeks (late pregnancy) and risks of a small-for-gestational-age (SGA) birth or stillbirth. We further estimated whether an increase in DBP from early to late pregnancy affected these risks. We found that 11% of the study population had prehypertension in late pregnancy. Prehypertension was associated with increased risks of both SGA birth and stillbirth; adjusted odds ratios (95% confidence intervals) were 1.69 (1.51-1.90) and 1.70 (1.16-2.49), respectively. Risks of SGA birth in term pregnancy increased by 2.0% (95% confidence intervals 1.5-2.8) per each mm Hg rise in DBP from early to late pregnancy, whereas risk of stillbirth was not affected by rise in DBP during pregnancy. We conclude that prehypertension in late pregnancy is associated with increased risks of SGA birth and stillbirth. Risk of SGA birth was also affected by rise in DBT during pregnancy. Our findings provide new insight to the relationship between maternal blood pressure and fetal well-being and suggest that impaired maternal perfusion of the placenta contribute to SGA birth and stillbirth. (Hypertension.
G estational hypertension and preeclampsia are associated with increased risks of intrauterine growth restriction and stillbirth. 1, 2 In these pregnancy hypertensive disorders, maternal blood pressure is elevated to or above the threshold of systolic blood pressure 140 mm Hg or diastolic blood pressure (DBP) of 90 mm Hg. 3 Prehypertension is defined as a systolic blood pressure of 120 to 139 mm Hg or a DBP of 80 to 89 mm Hg. 4 In nonpregnant adults, prehypertension has an association with cardiovascular mortality, especially deaths caused by stroke. 5 We are only aware of one study on prehypertension in pregnancy and risks of adverse fetal outcomes. This study was small, but the results indicate that prehypertension at 32 gestational weeks is associated with a slightly increased risk of a small-for-gestational-age (SGA) birth. 6 During normal pregnancy, blood pressure generally decreases from the first trimester to around 20 gestational weeks and thereafter increase until delivery. 7 Larger increases in blood pressures from the early second to the third trimester are related to reduced fetal growth [8] [9] [10] [11] and increased risk of pregnancy hypertensive disorders. 12 The influence of changes in blood pressure during pregnancy on fetal outcomes in nonhypertensive women is not fully known. One study reports reduced fetal growth with increasing blood pressure during pregnancy, 8 whereas other studies report no association between increasing blood pressure and adverse fetal outcome in nonhypertensive women. 13, 14 We hypothesized that prehypertension in late pregnancy is associated with increased risks of adverse fetal outcomes and that these risks vary by change in blood pressure during pregnancy.
In a population-based cohort of >150 000 singleton term pregnancies, we estimated associations between prehypertension in late pregnancy and risks of SGA birth and stillbirth. Further, we estimated how change in blood pressure between early and late pregnancy influenced these risks.
Methods

Data Sources
Data on maternal, delivery, and infant characteristics were obtained from the Swedish population-based Stockholm-Gotland Obstetric Database, 15 based on the medical record system used in the region for all antenatal, delivery, and postnatal care units. Data from the medical record system is daily forwarded to the database, which contains information from 2008 and onwards.
In Sweden, antenatal and delivery care is standardized and free of charge. Home deliveries are rare. During the first antenatal visit, the mother is interviewed about her medical and reproductive history and smoking habits. The mother's blood pressure and weight are measured and recorded, whereas information on maternal height is self-reported. Blood pressure is thereafter remeasured and recorded at each antenatal visit, standardized to around gestational week 10 (first antenatal visit), 25, and thereafter every second week in primiparous women and every third week in parous women until delivery. The database includes blood pressure measures from both outpatient and hospital care.
Study Population
From January 1, 2008, to October 22, 2014 , the database included information on 167 695 singleton births at 37 completed gestational weeks or later (Figure 1 ). We excluded 10 249 pregnancies with hypertensive disorders (definitions of hypertensive disorders are provided in web appendix in the online-only Data Supplement).
Of 157 446 women without pregnancy hypertensive disorders, we excluded 6759 (4.3%) women with missing data on blood pressure value between 34 and 36 gestational weeks (late pregnancy). Seventythreethousand ninety-four (49%) of the blood pressure measurements were included from 36 gestational weeks, and the corresponding numbers from gestational weeks 35 and 34 were 61 666 (41%) and 15 927 (11%), respectively. In analyses of changes in blood pressure during pregnancy and fetal outcomes, we also excluded 8928 (5.7%) women with missing data on blood pressure value before 20 gestational weeks (early pregnancy).
Exposure
The main exposure was DBP at 36 completed gestational weeks (late pregnancy). We selected the last recorded measurement before term (37 gestational weeks). If the woman had no recorded blood pressure measure at 36 gestational weeks, we used the most recent value. DBP measure was first categorized into 6 groups according to Table 1 and thereafter recategorized into presence of prehypertension (prehypertension group) or not (normotension group). Prehypertension was defined as a DBP 80 to 89 mm Hg. 4 Consequently, the normotension group included women with a DBP below 80 mm Hg.
We also wanted to investigate how blood pressure changes from early (first antenatal visit) to late pregnancy affected outcomes. Women were, therefore, categorized into (1) normotensive in late Women with chronic hypertension, gestational hypertension, or preeclampsia were excluded. BMI indicates body mass index.
*Defined as a birth weight of >2 standard deviations below the mean weight for gestational age, according to the Swedish sex-specific fetal growth curve. Only live births were included and 163 pregnancies were excluded because of missing information on birth weight and gestational age.
pregnancy and <15 mm Hg rise in DBP between early and late pregnancy; (2) normotensive and at least 15 mm Hg rise; (3) prehypertensive and <15 mm Hg rise; and (4) prehypertensive and at least 15 mm Hg rise. If a woman had several blood pressure measurements before 20 gestational weeks, we used the first recorded measurement.
Blood pressure was measured in the supine position on the right upper arm using manual blood pressure equipment with a cuff size appropriate for arm circumference. Korotkoff V was used for DBP.
Outcomes
Outcomes were giving birth to a live-born SGA infant or a stillbirth at 37 completed gestational weeks or later. SGA was defined as a birth weight of >2 standard deviations below the mean weight for gestational age according to the Swedish sex-specific fetal growth curve. 16 Gestational age was determined using the following hierarchy: (1) date of embryo transfer (3.0%); (2) early second trimester ultrasound (95.2%); (3) date of last menstrual period (1.8%); and (4) from a postnatal assessment (<1%). In SGA analyses, we only included live births, and 163 pregnancies were excluded because of missing information on birth weight or gestational age. Stillbirths include both antepartal and intrapartal deaths from 22 gestational weeks and onwards.
Covariates
Covariates were maternal age at delivery, parity, early pregnancy body mass index (BMI), maternal height, smoking habit in early pregnancy, living with a partner, and presence of pregestational or gestational diabetes mellitus. Pregestational and gestational diabetes mellitus were defined by corresponding codes provided in the International Classification of Diseases, tenth revision, provided by the responsible doctor at discharge from the hospital after delivery (International Classification of Diseases codes are provided in web appendix in the online-only Data Supplement). The covariates were categorized as in Table 1 .
Statistical Analyses
We calculated associations between DBP in late pregnancy and risks of an SGA birth or a stillbirth at 37 completed gestational weeks or later. Odds ratios with 95% confidence intervals (CIs) were calculated, using SAS PROC GENMOD in Statistical Analysis Software version 9.4 (SAS Institute Inc, Cary, NC). Adjusted odds ratios (aOR) were calculated after accounting for possible influence of maternal age, parity, BMI, height, smoking habit, living with a partner, and presence of diabetes mellitus. To estimate risks of SGA birth and stillbirth by DBP in late pregnancy, we first analyzed DBP as a continuous variable. Thereafter, DBP values were categorized into 6 groups using 60 to 64 mm Hg as reference group (Table 1) , and finally we dichotomized DBP values into normo-and prehypertension using normotension as reference group. To estimate the association between rise in DBP from early to late pregnancy and risks of SGA birth and stillbirth, we analyzed change in blood pressure as a continuous variable. Finally, we stratified normotensive and prehypertensive women in late pregnancy into 2 groups each depending on if the rise in DBP from early to late pregnancy was less than or at least 15 mm Hg. We used women with normotension and a rise in DBP of <15 mm Hg as the reference group.
Effect measure modification was investigated by introducing cross product terms between prehypertension and early pregnancy BMI and parity as categorical variables in the regression models of each outcome; a value of P<0.05 was considered significant.
Results
Maternal characteristics and rates and risks of prehypertension at 36 gestational weeks are presented in Table S1 in the online-only Data Supplement. Prehypertension was present in 16 864 women (11.2%) at 36 gestational weeks. Rates and risks of prehypertension in late pregnancy increased rapidly with maternal DBP in early pregnancy, moderately with early pregnancy BMI, and slightly with maternal height. Prehypertension was more common in primiparous versus parous women, in women who were living with their partner versus those who did not, and in women with diabetes mellitus versus those without diabetes mellitus. Maternal age and smoking habits did not influence prehypertension risk. Table 1 illustrates rates of SGA and stillbirth by maternal characteristics. Rates of SGA birth had a J-shaped association with DBP, a U-shaped association with maternal age, and increased with decreasing maternal BMI and height. The rate of stillbirth was doubled in women with prehypertension compared with the other blood pressure groups, increased with increasing maternal age and decreasing maternal height, and had a J-shaped association with maternal BMI. Rates of SGA and stillbirth were higher in nulliparous than in parous women, in smokers than in nonsmokers, and in women not living with a partner compared with their cohabiting counterparts. Diabetic mellitus during pregnancy was associated with reduced rates of SGA birth and increased rates of stillbirth.
The risks of SGA birth increased by 2.5% (95% CI 1.8-3.0) per mm Hg in DBP at 36 gestational weeks, whereas corresponding stillbirth risk was not significantly increased (1.5% [95% CI −0.5 to 3.6]; data not shown in table or figure) . Compared with normotensive women (DBP <80 mm Hg) at 36 gestational weeks, women with prehypertension (DBP 80-89 mm Hg) had a 70% increased risk of both SGA birth and stillbirth (Table 2 ). There was no interaction between prehypertension and early pregnancy BMI or parity concerning the risk of SGA (P=0.40 and P=0.46, respectively) or stillbirth (P=0.20 and 0.52, respectively). Intrauterine growth Figure 2 . Diastolic blood pressure at 36 gestational weeks and adjusted odds ratios (aOR) of giving birth to a live small-for-gestational-age infant in term nonhypertensive pregnancies. Risks were adjusted for maternal age, parity, early pregnancy body mass index, maternal height, smoking habit in early pregnancy, living with partner or not, and presence of pregestational or gestational diabetes mellitus. restriction is a common cause of stillbirth. 2 When we reanalyzed the risk of stillbirth in women with prehypertension after excluding pregnancies complicated by SGA, the risk was slightly attenuated; the aOR (95% CI) was 1.62 (1.07-2.45; not shown in table).
Risk of SGA birth in term pregnancy increased by 2.0% (95% CI 1.5-2.8) per each mm Hg rise in DBP from early to late pregnancy. However, risk of stillbirth was not affected by rise in DBP during pregnancy (0.0%; 95% CI −1.4 to 1.7).
Next, normotensive and prehypertensive women at 36 gestational weeks were stratified by increase in DBP since early pregnancy (less or at least 15 mm Hg, respectively). Compared with normotensive women with an increase in DBP of <15 mm Hg, all other exposure groups had increased risks of SGA birth (Table 3) . Prehypertensive women in late pregnancy whose DBP had increased at least 15 mm Hg from early pregnancy had the highest rate (3.6%) and risk (aOR 2.39; 95% CI 2.01-2.84). The increased stillbirth risk was restricted to prehypertensive women who had an increase of <15 mm Hg in DBP since early pregnancy.
Discussion
In this large population-based study including nonhypertensive pregnant women with term births, we showed that prehypertension in late pregnancy was associated with a 70% increased risk of both SGA birth and stillbirth. These findings are of major importance because prehypertension in late pregnancy is common, with an incidence of 11% in our study population. Further, we showed that an increase in DBP of at least 15 mm Hg from early to late pregnancy increased the risk of SGA birth also in pregnancies that had not reached the level of prehypertension in late pregnancy.
Comparisons to Earlier Studies
We found a dose-response association between high DBP in late pregnancy and risk of SGA birth in nonhypertensive pregnancies, with the highest risk seen in women with prehypertension. We are only aware of 2 earlier studies on the effect of level of blood pressure in nonhypertensive pregnancies on fetal growth, 6, 9 and both studies report results in accordance with ours. One small Japanese study found that women with prehypertension at 32 gestational weeks had a slightly increased risk of SGA birth (odds ratio 1.09; 95% CI 1.01-1.17) compared with normotensive women. 6 The study only included 71 women with prehypertension, and adjustments were solely made for maternal BMI. The second study reports the highest birth weights in pregnancies where the highest recorded DBP during pregnancy was 80 mm Hg (at higher blood pressure levels, the birth weights decreased).
9
Our results are further supported by a recent study of normotensive women, reporting a higher blood pressure in women carrying a growth-restricted compared with a normal sized fetus. 17 We could not confirm previous findings of associations between hypotension and increased risks of both SGA birth 10 and stillbirth. 9, 18, 19 The divergent findings might be explained by differences in study design. We used information about blood pressure at 36 weeks, whereas earlier studies used information of the highest measured blood pressure during pregnancy. Our study was restricted to term deliveries, whereas preterm deliveries were also included in earlier studies. Further, one of the former studies 9 included total perinatal mortality.
Before the millennium shift, a rise of at least 15 mm Hg in DBP during pregnancy was diagnosed as hypertension in national and international guidelines even if the threshold of 90 mm Hg was not reached. 13 This definition was omitted because of data that did not support any adverse maternal or fetal outcomes in these women, 20, 21 and that a large proportion of women demonstrate such increase in blood pressure. 7, 20 However, the results of our study reintroduce that we should have an alertness of pregnancies where the DBP increases at least 15 mm Hg during the pregnancy. Special attention to an increase in blood pressure should be considered in women with prehypertension in late pregnancy because our findings indicate an association with 2.4-fold increased risk of SGA birth in these pregnancies. This finding is in accordance with a recent report from the Avon Longitudinal Study of Parents and Children (ALSPAC), 8 reporting an association between increasing maternal blood pressure levels during pregnancy and reduced fetal growth also in women whose blood pressure does not cross the threshold for pregnancy hypertensive disorders.
Potential Explanations for the Associations Between Prehypertension and SGA Birth and Stillbirth
During pregnancy, the mother undergoes physiological adaptation with increases in plasma volume and cardiac output and Women with chronic hypertension, gestational hypertension, or preeclampsia are excluded. aOR indicates adjusted odds ratios; and CI, confidence interval.
*Defined as a birth weight of >2 standard deviations below the mean weight for gestational age, according to the Swedish sex-specific fetal growth curve. In analysis of SGA, only live births were included and 163 pregnancies were excluded because of missing information on birth weight and gestational age.
†Adjusted for maternal age, parity, early pregnancy body mass index (BMI), maternal height, smoking habit in early pregnancy, living with partner or not, and presence of pregestational or gestational diabetes mellitus.
by guest on September 23, 2017 http://hyper.ahajournals.org/ Downloaded from a decrease in total peripheral resistance. 22, 23 These changes might facilitate uteroplacental perfusion and thereby fetal oxygenation and nutrition. Normotensive pregnancies with fetal growth restriction have, compared with those without fetal growth restriction, a higher total peripheral resistance and reduced cardiac output already in early pregnancy. 24 Similar but even more severe insufficient maternal physiological adaptation has been shown in pregnancies complicated with preeclampsia. 17, 25 Intrauterine growth restriction and preeclampsia are closely linked with abnormal placentation. 26, 27 Reduced uteroplacental perfusion has been shown to induce a rise in maternal blood pressure through increased production of vasoconstrictive agents. [28] [29] [30] We speculate that differences in efficiency of maternal cardiovascular adaptation might explain why some women with fetal growth restriction (and reduced uteroplacental perfusion) increase their blood pressure beyond the threshold of pregnancy hypertensive disorder, whereas others do not. Probably, some women with blood pressure levels below the hypertension threshold would have passed this threshold later in pregnancy if not birth had intervened.
We could only show an association between prehypertension in late pregnancy and stillbirth in pregnancies with <15 mm Hg increase since early pregnancy, indicating that a blood pressure in the higher normal range during the entire pregnancy may be harmful for the fetus. When we excluded pregnancies with SGA births, the association between prehypertension and stillbirth was only slightly attenuated. This might question that fetal growth restriction is in the causal pathway between prehypertension and stillbirth risk. Still, recent reports suggest that placental insufficiency and fetal growth restriction may also be present in term pregnancies with fetuses of normal size. 31, 32 Prehypertension in nonpregnant populations is associated with micro-and macrovascular pathology, 33, 34 enhanced oxidative stress, 35 increased levels of inflammatory markers, 36 and microalbuminuria (a marker of endothelial dysfunction). 37 These characteristics are also seen in pregnancies complicated with placental insuffiency, 38 which give us further support for an association between prehypertension and placental disorders.
Strengths and Limitations
The main strengths of this investigation are the populationbased study design, the prospectively recorded information of blood pressure levels during pregnancy, and the large cohort size. The population had antenatal and obstetric care that was free of charge, and management routines were standardized. Such factors should minimize the potential for confounding by unmeasured sociodemographic factors or differences in management. In our study, we had the ability to adjust for several important confounders, such as maternal age, smoking, early pregnancy BMI, and diabetes mellitus. 39, 40 However, we did not have data on weight gain during pregnancy, which can affect blood pressure trajectories during pregnancy 39 and also the association with SGA. 41 Nor we had data on maternal ethnicity, which can affect both blood pressure trajectories during pregnancy and our outcomes. 39, 42, 43 Blood pressure measurements were collected during routine antenatal appointments by midwifes, and the measurements can, therefore, have inherent and interobserver variability. This would, however, only expect to introduce random rather than systemic error.
Perspectives
Maternal prehypertension in late pregnancy is associated with increased risks of SGA birth and stillbirth. Further, risk of SGA birth increased by 2% per mm Hg increase in DBP from early to late pregnancy. Still, we do not suggest blood pressure medication in these women because earlier studies have failed to show improved fetal outcome when lowering blood pressures below a prehypertensive level. 44 The greatest impact of our findings is probably the improved insight to the relationship between maternal blood pressure, placental function, and fetal wellbeing. Our data implies that both impaired maternal perfusion of Women with chronic hypertension, gestational hypertension, or preeclampsia are excluded. AOR indicates adjusted odds ratio; and CI, confidence interval.
by guest on September 23, 2017 http://hyper.ahajournals.org/ Downloaded from the placenta (an extrinsic defect) and impaired placental development (an intrinsic defect) may lead to SGA and stillbirth. 
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